The University Of Tennessee Health Science Center
Post-Doctoral Fellow – National Institute on Drug Abuse
The University Of Tennessee Health Science Center, Baltimore, Maryland, United States, 21276
Overview
Post-Doctoral Fellow – National Institute on Drug Abuse The Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN) Section is a translational and clinical laboratory of the NIH Intramural Research Program, jointly funded by NIDA and NIAAA, currently recruiting a Post-Doctoral Fellow. The workplace is located in Baltimore, MD. The Post-Doctoral fellow will be involved in a variety of projects and clinical protocols relevant to the laboratory, under the supervision and mentoring of Dr. Lorenzo Leggio, Principal Investigator, Senior Investigator (Clinical) and Chief. The laboratory conducts human clinical and translational inpatient and outpatient studies to identify possible novel medications for addiction. The goal of these studies is to identify and develop novel effective treatments for alcohol and substance use disorders. The focus is on studying novel pathways related to the microbiome-gut-liver-brain axis, neuroendocrine pathways, and other approaches aimed at improving understanding and treatment of addictions. The selected candidate will have access to lectures, educational, mentoring and grant training opportunities at the lab-level, and NIH-wide. Responsibilities
The Post-Doctoral Fellow will contribute to ongoing projects and clinical protocols within the laboratory, under supervision and mentoring. To apply
Send current CV, a statement of research background and interests, and at least 3 reference contacts to: Dr. Lorenzo Leggio, M.D., Ph.D., Email: lorenzo.leggio@nih.gov Contact
Contact name: Dr. Lorenzo Leggio Contact email: lorenzo.leggio@nih.gov Qualifications
An M.D., Ph.D., or equivalent degree is required. The ideal candidate will have a strong background and skillset related to addiction, mental health and neuroscience. Experience in carrying over experimental medicine and human laboratory studies with research volunteers, including participants with alcohol and substance use disorders, is preferred.
#J-18808-Ljbffr
Post-Doctoral Fellow – National Institute on Drug Abuse The Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN) Section is a translational and clinical laboratory of the NIH Intramural Research Program, jointly funded by NIDA and NIAAA, currently recruiting a Post-Doctoral Fellow. The workplace is located in Baltimore, MD. The Post-Doctoral fellow will be involved in a variety of projects and clinical protocols relevant to the laboratory, under the supervision and mentoring of Dr. Lorenzo Leggio, Principal Investigator, Senior Investigator (Clinical) and Chief. The laboratory conducts human clinical and translational inpatient and outpatient studies to identify possible novel medications for addiction. The goal of these studies is to identify and develop novel effective treatments for alcohol and substance use disorders. The focus is on studying novel pathways related to the microbiome-gut-liver-brain axis, neuroendocrine pathways, and other approaches aimed at improving understanding and treatment of addictions. The selected candidate will have access to lectures, educational, mentoring and grant training opportunities at the lab-level, and NIH-wide. Responsibilities
The Post-Doctoral Fellow will contribute to ongoing projects and clinical protocols within the laboratory, under supervision and mentoring. To apply
Send current CV, a statement of research background and interests, and at least 3 reference contacts to: Dr. Lorenzo Leggio, M.D., Ph.D., Email: lorenzo.leggio@nih.gov Contact
Contact name: Dr. Lorenzo Leggio Contact email: lorenzo.leggio@nih.gov Qualifications
An M.D., Ph.D., or equivalent degree is required. The ideal candidate will have a strong background and skillset related to addiction, mental health and neuroscience. Experience in carrying over experimental medicine and human laboratory studies with research volunteers, including participants with alcohol and substance use disorders, is preferred.
#J-18808-Ljbffr